Semaglutide offers heart health benefits independent of weight loss

medicalnewstoday.com

Semaglutide, found in Ozempic and Wegovy, reduces heart attack and stroke risk regardless of weight loss, a new study reveals. The research analyzed over 17,000 adults, showing the drug's cardiovascular benefits are not solely due to weight reduction, suggesting a direct impact on heart disease causes. This finding indicates semaglutide may benefit individuals with normal BMIs but cardiovascular disease, expanding its potential therapeutic applications beyond weight management.


With a significance score of 6, this news ranks in the top 0.3% of today's 32258 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: